TriLink BioTechnologies, part of Maravai LifeSciences

TriLink BioTechnologies, a subsidiary of Maravai LifeSciences, is a San Diego-based contract development and manufacturing organization (CDMO) established in 1996. The company specializes in high-quality nucleic acid and mRNA solutions for various applications, including research, diagnostics, and therapeutics. With over 25 years of experience, TriLink operates manufacturing facilities that comply with industry standards such as ISO 9001 and 21 CFR regulations. TriLink offers a wide range of products, including proprietary mRNA solutions featuring CleanCap® technology, custom nucleotides, and oligonucleotides. The company also provides contract development and manufacturing services, focusing on the synthesis and scale-up of nucleic acids and mRNA production. TriLink partners with distributors to expand its nucleic acid solutions globally, serving a diverse clientele that includes pharmaceutical companies, biotech firms, academic institutions, and government agencies. Their work supports advancements in areas like oncology, infectious diseases, and gene therapy, contributing to rapid vaccine development and pandemic preparedness.